BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Business Monitor International Strengthens its Pharmaceutical and Medtech Portfolio With Acquisition of Espicom Business Intelligence


8/22/2012 1:24:34 PM

London, UK, August 21 2012 - Business Monitor International (“BMI”) has announced the acquisition of Espicom Business Intelligence (“Espicom”), a UK-based company with a 30-year pedigree providing business intelligence on Medical Devices, Pharmaceuticals & Healthcare and Therapeutics across global markets. The acquisition reflects BMI’s commitment to deepening its market coverage of more than 20 industry verticals with specialist product and company intelligence. The financial terms of the transaction have not been disclosed.

The acquisition brings to BMI Espicom’s wide-range of information and business intelligence services for the global healthcare industries. In medical technology and devices, Espicom’s service features coverage of key operators in 70 country markets, proprietary 5-year forecasts, daily news on key technologies and critical management reports on areas such as advanced wound care, diagnostic products and market access. In pharmaceuticals, Espicom’s service features country-level data, therapeutics, generics and biosimilars markets coverage and specialized drug development database services.

BMI co-CEO Jonathan Feroze commented that “Espicom’s product and company level content, combined with BMI’s existing pharmaceuticals and healthcare coverage across 97 countries, will produce a holistic, market-leading offering”. Co-CEO Richard Londesborough added that “the acquisition of Espicom deepens our content portfolio in a highly strategic growth segment for BMI”.

Espicom founder and CEO Eric Wigart, added that “BMI is the ideal platform for bringing Espicom’s content to a wider audience. Leveraging BMI’s global research, sales and account management capabilities will be a win-win for both companies”.

About Business Monitor International

Head-quartered in London, Business Monitor International (“BMI”) provides multinational corporations, financial institutions and government with integrated country risk, financial markets and industry research across 170 country markets and more than 20 industry verticals, with unrivalled coverage of emerging and frontier markets. Business Monitor Online, the company’s flagship online subscription service, features timely analysis, proprietary forecasts and risk ratings and rankings. Backed since 2009 by Spectrum Equity Investors, BMI has achieved rapid organic growth over the last decade, and now counts more than 400 of the Fortune Global 500 among its clients.

Contacts

Matthew Brooks

Business Monitor International

• mbrooks@businessmonitor.com

• Tel: +44 (0)207 246 5117

Nigel Chivers

Espicom Business Intelligence

• Nigel_chivers@espicom.com

• Tel: +44 (0)7793 211899



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->